Bone morphogenetic proteins (BMPs) are naturally occurring proteins found in the human body. This family of proteins is involved in a myriad of cellular responses. Certain BMPs are osteoinductive?one of the three main categories of bone grafts?and play an active role in bone formation and maintenance. Scope of the Report: This report focuses on the Bone Morphogenetic Protein (BMP) 2 in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application. The classification of Bone Morphogenetic Protein (BMP) 2 includes sponge and gel types, and the proportion of sponge in 2016 is about 99%, and the proportion will be in decreasing trend from 2017 to 2022. Bone Morphogenetic Protein (BMP) 2 is widely used in spinal fusion, trauma surgery, oral maxillofacial surgery and reconstructive. The most proportion of Bone Morphogenetic Protein (BMP) 2 is used in spinal fusion, and the consumption proportion is about 62% in 2016. North America is the largest consumption place, with a consumption market share nearly 70% in 2016. Following North America, Europe is the second largest consumption place with the consumption market share of 20%. Market competition is concentrated. Medtronic and Cellumed are the leaders of the industry, and they hold key technologies and patents, with high-end customers; have been formed in the monopoly position in the industry. The worldwide market for Bone Morphogenetic Protein (BMP) 2 is expected to grow at a CAGR of roughly 2.0% over the next five years, will reach 430 million US$ in 2023, from 390 million US$ in 2017, according to a new GIR (Global Info Research) study. Market Segment by Manufacturers, this report covers Medtronic Cellumed Market Segment by Regions, regional analysis covers North America (United States, Canada and Mexico) Europe (Germany, France, UK, Russia and Italy) Asia-Pacific (China, Japan, Korea, India and Southeast Asia) South America (Brazil, Argentina, Colombia etc.) Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Market Segment by Type, covers Sponge Gel Market Segment by Applications, can be divided into Spinal Fusion Trauma Surgery Oral Maxillofacial Surgery Reconstructive There are 15 Chapters to deeply display the global Bone Morphogenetic Protein (BMP) 2 market. Chapter 1, to describe Bone Morphogenetic Protein (BMP) 2 Introduction, product scope, market overview, market opportunities, market risk, market driving force; Chapter 2, to analyze the top manufacturers of Bone Morphogenetic Protein (BMP) 2, with sales, revenue, and price of Bone Morphogenetic Protein (BMP) 2, in 2016 and 2017; Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017; Chapter 4, to show the global market by regions, with sales, revenue and market share of Bone Morphogenetic Protein (BMP) 2, for each region, from 2013 to 2018; Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions; Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018; Chapter 12, Bone Morphogenetic Protein (BMP) 2 market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023; Chapter 13, 14 and 15, to describe Bone Morphogenetic Protein (BMP) 2 sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source
Table of Contents 1 Market Overview 1.1 Bone Morphogenetic Protein (BMP) 2 Introduction 1.2 Market Analysis by Type 1.2.1 Sponge 1.2.2 Gel 1.3 Market Analysis by Applications 1.3.1 Spinal Fusion 1.3.2 Trauma Surgery 1.3.3 Oral Maxillofacial Surgery 1.3.4 Reconstructive 1.4 Market Analysis by Regions 1.4.1 North A
